Gastrointestinal Market Research Reports & Industry Analysis
While many of these illnesses are chronic and can only be treated medically, more holistic and natural approaches are being used more frequently to prevent and manage gastrointestinal disorders. Many healthcare providers are recommending stress management, a healthy diet, and exercise to prevent and manage symptoms.
Exercise has shown to decrease the risk of colon cancer, minimize constipation and improve overall GI health. Even minimal exercise paired with a healthy diet of fruits, vegetables, low fat protein and avoidance of red meat, animal fat, and processed meats, can go a long way in preventing colon cancer and other GI diseases.
It is known that psychological stress can aggravate symptoms of Crohn’s disease, irritable bowel syndrome, and ulcerative colitis. Taking a mind-body approach to health can help these patients manage their illnesses. Techniques such as yoga, meditation, massage, and acupuncture can lower stress and in turn reduce bowel symptoms. Doctors also recommend an anti-inflammatory diet (omega-3 fatty acids, fruits & vegetables, and protein rich food like fish, chicken and soy) for people suffering from Crohn’s disease.
Gastrointestinal Industry Research & Market Reports
-
Global Gastrointestinal Drugs Market Insights, Forecast to 2029
... reach a revised size of US$ 53820 million by 2029, growing at a CAGR of 4.67% during the forecast period 2023-2029. The North America market for Gastrointestinal Drugs is estimated to increase from $ 12575 ... Read More
-
Irritable Bowel Syndrome Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... market to reach US$ 4.2 Billion by 2028, exhibiting a growth rate (CAGR) of 9.03% during 2022-2028. Irritable bowel syndrome (IBS) refers to a chronic medical condition that affects the large intestine. It is usually ... Read More
-
Patient Derived Xenograft Model Market, By Model Type (Cell line derived models, Patient derived organoids, Genetically engineered models and Others (Primary cell derived models, cell processed models etc.)), By Implantation Method (Subcutaneous Implantation, Orthopedic Implantation and Others), By Tumor Type (Blood Cancer Models, Solid Tumor Models, Pediatric Tumor Models, Other Rare Tumor Models, Combination PDX Models, Custom PDX Models, Others), By Application (Gastrointestinal Tumor Model, Gynecological Tumor Model, Respiratory Tumor Model and Other Tumor Model), By End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Academic & Research Institutions, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... and Others), By Tumor Type (Blood Cancer Models, Solid Tumor Models, Pediatric Tumor Models, Other Rare Tumor Models, Combination PDX Models, Custom PDX Models, Others), By Application (Gastrointestinal Tumor Model, Gynecological Tumor Model, Respiratory Tumor ... Read More
-
Global Helicobacter Pylori Non-Invasive Testing Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... market growth of the Helicobacter Pylori Non-Invasive Testing industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Helicobacter Pylori Non-Invasive Testing. The report ... Read More
-
Digestive Health Products Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 71.6 Billion by 2028, exhibiting a growth rate (CAGR) of 7.9% during 2022-2028. Digestive health products refer to various edible products consumed to maintain optimum levels of acid in the stomach and enhance ... Read More
-
Global Stool Testing Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Canada Clinical Nutrition Market, By Nutrition Type (Enteral Nutrition (Standard Nutrition, Disease Specific Nutrition), Parenteral Nutrition (Amino Acid, Carbohydrates, Vitamins and Minerals, Others (Proteins, Lipids among Others))), By Form (Powder, Liquid, Tablets, Capsules, Gummies, Others (Nutrition Bar, among Others)), By Route of Administration (Oral, Enteral, Parenteral), By Age Group (Infant Nutrition, Adult Nutrition, Geriatric Nutrition), By Application (Diabetes, Cancer, Critical Care, Neurological Disorder, Metabolic Syndrome, Gastrointestinal Diseases, Other (Cardiovascular Diseases and Others)), By End User (Hospitals, Ambulatory Surgical Centers, Long Term Care Facilities)
... (Nutrition Bar, among Others)), By Route of Administration (Oral, Enteral, Parenteral), By Age Group (Infant Nutrition, Adult Nutrition, Geriatric Nutrition), By Application (Diabetes, Cancer, Critical Care, Neurological Disorder, Metabolic Syndrome, Gastrointestinal Diseases, Other (Cardiovascular Diseases ... Read More
-
Enteral Feeding Devices Market, By Product Type ( Feeding Tubes( Nasogastric Tube with ENFit Connector, Orogastric Tube, Nasoenteric Tube, Oroenteric Tube, Gastrostomy Tube (G Tube) with ENFit Connector, Jejunostomy Tubes), By Age Group (ediatric, Adults), By Application (Diabetes, Oncology, Gastrointestinal Diseases, Hypermetabolism, Others), By End User (Hospitals, Ambulatory Surgical Centers, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... By Application (Diabetes, Oncology, Gastrointestinal Diseases, Hypermetabolism, Others), By End User (Hospitals, Ambulatory Surgical Centers, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific) Enteral Feeding Devices Market, By ... Read More
-
2023 Diseases of the Digestive System Global Market Size & Growth Report with COVID-19 & Recession Risk Impact
... revenue, growth, and share across 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 216 countries. Figures are from 2014 through 2022, with forecasts for 2023 and 2027. ... Read More
-
Hospital Infection Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... market to reach US$ 15.8 Billion by 2028, exhibiting a growth rate (CAGR) of 4.8% during 2023-2028. Hospital infection therapeutics refers to various pharmaceutical drugs used for the treatment of nosocomial infections. These infections can ... Read More
-
Enteral Feeding Devices Market by Product (Administration Sets, Enteral Feeding Pumps, Enteral Feeding Tubes), Application (Diabetes, Gastroenterology, Hypermetabolism), End-User - Global Forecast 2023-2030
... in 2022 and expected to reach USD 4.34 billion in 2023, at a CAGR 7.33% to reach USD 7.16 billion by 2030 . Market Segmentation & Coverage: This research report analyzes various sub-markets, forecasts revenues, ... Read More
-
Over-The-Counter Consumer Health Products Market by Indications (Gastrointestinal Products, Nutritional Supplements, Oral Care Products), Distribution Channel (Hospital Pharmacy, Hypermarkets & Supermarkets, Independent Pharmacies & Retail Stores) - Globa
... Market size was estimated at USD 42.02 billion in 2022 and expected to reach USD 43.94 billion in 2023, at a CAGR 4.71% to reach USD 60.74 billion by 2030. Market Segmentation & Coverage: This ... Read More
-
Macrolide Antibiotics Market By Drug Type (Azithromycin, Erythromycin, Others), By Route of Administration (Oral, Parenteral, Others), By Indication (Respiratory Tract Infections, Skin Infections, Sexually Transmitted Infections, Gastrointestinal Infections, Others), By Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Providers): Global Opportunity Analysis and Industry Forecast, 2023-2032
... Stores and Retail Pharmacies, Online Providers): Global Opportunity Analysis and Industry Forecast, 2023-2032 The macrolide antibiotics market was valued at $5.6 billion in 2022 and is estimated to reach $7.0 billion by 2032, exhibiting a ... Read More
-
In Vitro Diagnostics Market By Product and Services (Reagents and Kits, Instruments, Software and Services), By Technique (Immunodiagnostics, Hematology, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, Others), By Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, Others), By End User (Standalone Laboratories, Hospitals, Academic and Medical Schools, Point of Care, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
... Disorders, Nephrological Diseases, Gastrointestinal Diseases, Others), By End User (Standalone Laboratories, Hospitals, Academic and Medical Schools, Point of Care, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032 The in vitro diagnostics market was valued at ... Read More
-
U.S. Clinical Nutrition Market, By Type (Enteral Nutrition (Standard Nutrition and Disease Specific Nutrition) and Parenteral Nutrition (Amino Acids, Carbohydrates, Vitamins and Minerals and Others (Fibers, etc.)), By Form (Powder, Liquid and Others (Solid,etc.)), By Age Group (Infant Nutrition, Adult Nutrition and Geriatric Nutrition), By Application (Diabetes, Gastrointestinal Diseases, Cancer, Neurological Disorder, Metabolic Syndrome and Other (Critical Care, etc.)), By End User (Hospitals, Home Care Setting, Long Term Care Facilities, Ambulatory Surgical Centers and Others (Research Institutes, etc.))
... Age Group (Infant Nutrition, Adult Nutrition and Geriatric Nutrition), By Application (Diabetes, Gastrointestinal Diseases, Cancer, Neurological Disorder, Metabolic Syndrome and Other (Critical Care, etc.)), By End User (Hospitals, Home Care Setting, Long Term Care Facilities, ... Read More
-
United States Nutraceuticals Market Assessment, By Product Type [Dietary Supplements, Functional Foods, Functional Beverages], By Ingredient [Vitamins, Minerals, Fibers & Speciality Carbohydrates, Fatty Acid, Botanicals, Prebiotics & Probiotics, Proteins & Amino Acids, Others], By Dosage Forms [Capsules, Tablets, Gummies, Liquid Water Enhancer, Liquids, Powders, Others], By Flavours [Chocolate, Orange, Strawberry, Vanilla, Unflavoured, Others], By Application [Energy & Weight Management, Bone & Joint Health, General Health, Immunity, Gastrointestinal Health, Lungs Detox/Cleanse, Sexual Health, Skincare, Anti-Aging, Insomnia], By End-user [Men, Women, Kids], By Packaging [Plastics, Biopolymers, Paperboards, Others], By Distribution Channel [Hypermarkets/Supermarkets, Pharmacies, Speciality Stores, Practitioner, E-Retailers, Others], By Region, Opportunities and Forecast, 2016-2030F
... Forms [Capsules, Tablets, Gummies, Liquid Water Enhancer, Liquids, Powders, Others], By Flavours [Chocolate, Orange, Strawberry, Vanilla, Unflavoured, Others], By Application [Energy & Weight Management, Bone & Joint Health, General Health, Immunity, Gastrointestinal Health, Lungs Detox/Cleanse, ... Read More
-
Neonatal and Preterm Infants Enteral Feeding Devices Market, by Product Type (Enteral Feeding Pumps, Low Profile Gastrostomy, PEG Tube, Nasogastric Tube, Gastrostomy Tube, and Giving Set), by End User (Home Care Settings, Hospitals, and Others (Ambulatory Centers, etc.)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
... (Ambulatory Centers, etc.)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Neonatal and Preterm Infants Enteral Feeding Devices Market, by Product Type (Enteral Feeding Pumps, Low Profile Gastrostomy, PEG ... Read More
-
Irritable Bowel Syndrome (IBS) Treatment Global Market Report 2023 Including: 1) By Drug Type: Lubiprostone; Linaclotide; Eluxadoline; Rifaximin; Alosetron 2) By Indication: IBS With Constipation; IBS With Diarrhea; IBS With Alternating Constipation And Diarrhea 3) By Distribution Channel: Hospital Pharmacies; Online Pharmacies; Retail Pharmacies 4) By End-Users: Hospitals; Clinics; Homecare Settings Covering: Pfizer Inc.; Johnson & Johnson Services Inc.; AbbVie Inc.; Novartis AG; AstraZeneca plc
... Channel: Hospital Pharmacies; Online Pharmacies; Retail Pharmacies4) By End-Users: Hospitals; Clinics; Homecare SettingsCovering: Pfizer Inc.; Johnson & Johnson Services Inc.; AbbVie Inc.; Novartis AG; AstraZeneca plc Irritable Bowel Syndrome (IBS) Treatment Global Market Report 2023 ... Read More
-
Barrett's Esophagus Global Market Report 2023 Including: 1) By Type: No Dysplasia; Low-Grade Dysplasia; High Grade Dysplasia 2) By Treatment: Medication; Endoscopic Therapy; Surgery 3) By Route Of Administration: Oral; Parenteral; Rectal 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy Covering: F Hoffmann-La Roche Ltd.; Sanofi SA; AstraZeneca plc; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited
... Retail Pharmacy; Online PharmacyCovering: F Hoffmann-La Roche Ltd.; Sanofi SA; AstraZeneca plc; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited Barrett's Esophagus Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management ... Read More
-
South & Central America Enteral and Parenteral Medical Nutrition Market Forecast to 2028 - Regional Analysis By Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer’s Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18-60 Years, 3-18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)
... Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above ... Read More
-
Europe Enteral and Parenteral Medical Nutrition Market Forecast to 2028 - Regional Analysis By Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer’s Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18-60 Years, 3-18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)
... and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18-60 ... Read More
-
Asia Pacific Enteral and Parenteral Medical Nutrition Market Forecast to 2028 - Regional Analysis By Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer’s Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18-60 Years, 3-18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)
... COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, ... Read More
-
Middle East & Africa Enteral and Parenteral Medical Nutrition Market Forecast to 2028 - Regional Analysis By Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer’s Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18-60 Years, 3-18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)
... Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above ... Read More
-
North America Enteral and Parenteral Medical Nutrition Market Forecast to 2028 - Regional Analysis By Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer’s Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18-60 Years, 3-18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)
... COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, ... Read More
-
Global Stomach Cancer Treatment Market - 2023-2030
... the forecast period 2023-2030. Stomach cancer is a disease in which malignant (cancer) cells are formed in the stomach lining. Stomach cancer usually begins in the mucus-producing cells that line the stomach. Symptoms of stomach ... Read More
Research Assistance
